Stockreport

Salarius Pharmaceuticals Supports Childhood Cancer Awareness Month

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF HOUSTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancer, [Read more]